XBiotech Names Jan-Paul Simard Co-CEO Alongside Sushma Shivaswamy

• XBiotech appointed Sushma Shivaswamy and Jan-Paul Simard as co-CEOs, effective Oct. 23, 2026.
• Shivaswamy became interim CEO in December 2025, following her appointment as chief scientific officer in 2017.
• Simard joined in 2012 as a research and development assistant before moving to clinical development in 2020.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XBiotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610240807OMX_____CNEWS_FR_GNW9852551_fr) on October 24, 2026, and is solely responsible for the information contained therein.